| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/24/2005 | WO2005016315A1 Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler |
| 02/24/2005 | WO2005016314A1 Form of administration secured against misuse |
| 02/24/2005 | WO2005016313A1 Dosage form that is safeguarded from abuse |
| 02/24/2005 | WO2005016312A1 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 02/24/2005 | WO2005016311A1 Robust pellet |
| 02/24/2005 | WO2005016310A1 Novel metaxalone compositions |
| 02/24/2005 | WO2005016309A1 Cosmetic composition promoting oxygen transport into the skin |
| 02/24/2005 | WO2005016308A1 Macrolides containing oil-in-water emulsions |
| 02/24/2005 | WO2005016307A1 Steroidal compositions containing hydroxycarboxylic acids and methods of using the same |
| 02/24/2005 | WO2005016306A2 Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation |
| 02/24/2005 | WO2005016305A1 Temperature sensitive state-changing hydrogel composition and method for their preparation |
| 02/24/2005 | WO2005016294A1 Emulsions with a concentrated internal oil phase |
| 02/24/2005 | WO2005016293A1 Concentrated oil-in-water emulsions |
| 02/24/2005 | WO2005016284A2 Gloves containing dry powdered aloe and method of manufacturing |
| 02/24/2005 | WO2005016278A2 Antibiotic product, use and formulation thereof |
| 02/24/2005 | WO2005016275A2 Formulations containing an immune response modifier |
| 02/24/2005 | WO2005016273A2 Infection prophylaxis using immune response modifier compounds |
| 02/24/2005 | WO2005016257A2 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/24/2005 | WO2005016256A2 Hemostatic compositions containing sterile thrombin |
| 02/24/2005 | WO2005016225A2 Stable pharmaceutical composition of rabeprazole |
| 02/24/2005 | WO2005016031A1 Methods for reducing astringency |
| 02/24/2005 | WO2005015993A1 Insect control using attractants and insecticides stabilised in castor oil |
| 02/24/2005 | WO2005002642A3 Medication infusion device using negatively biased ambient pressure medication chamber |
| 02/24/2005 | WO2005000312A8 Sustained drug-relase particles and process for producing the same |
| 02/24/2005 | WO2004112630A3 A formulation and a process for reducing the deterioration of blood with particular reference to decrease in the level of 2,3 diphosphoglycerate during storage |
| 02/24/2005 | WO2004100876A3 The aerosolization of cromolyn sodium using a capillary aerosol generator |
| 02/24/2005 | WO2004099377A3 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 02/24/2005 | WO2004096150A3 Oral pharmaceutical delivery system with improved sustained release |
| 02/24/2005 | WO2004091529A3 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| 02/24/2005 | WO2004082668A8 Coenzyme q10-containing proliposome and preparation thereof |
| 02/24/2005 | WO2004071424A3 Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
| 02/24/2005 | WO2004071403A3 Coated particles and pharmaceutical dosage forms |
| 02/24/2005 | WO2004066939A3 Controlled-release drug delivery system |
| 02/24/2005 | WO2004010997A8 Sustained-release tablet composition of pramipexole |
| 02/24/2005 | WO2003105661A3 Materials with both bioadhesive and biodegradable components |
| 02/24/2005 | WO2003093503A3 Method for bioequivalence determination using expression profiling |
| 02/24/2005 | WO2003090721A3 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | US20050043788 Drug-eluting stent |
| 02/24/2005 | US20050043706 Sinus delivery of sustained release therapeutics |
| 02/24/2005 | US20050043696 Coated water-swellable material |
| 02/24/2005 | US20050043594 System and apparatus for remote activation of implantable medical devices |
| 02/24/2005 | US20050043481 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 02/24/2005 | US20050043457 microfuidic osmotic pumps comprising flexible containers encapsulated by solutes, semipermeable membranes encapsulating the solutes, seals and bores; drug delivery devices |
| 02/24/2005 | US20050043402 Methods and formulations for counteracting infection of mucosa or skin |
| 02/24/2005 | US20050043400 Mixture of zinc acetate and zinc gluconate; sustained release; bioavailability |
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
| 02/24/2005 | US20050043380 Composition for treatment of malignant tumors |
| 02/24/2005 | US20050043377 Thioflavin derivatives for use in the antemortem diagnosis of alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 02/24/2005 | US20050043375 Solid preparation containing single crystal form |
| 02/24/2005 | US20050043286 Use of an ascomycin for the treatment of blepharitis |
| 02/24/2005 | US20050043285 Formulation |
| 02/24/2005 | US20050043283 comprising a steroidal hormone (eg androgen) or anti-inflammatory agent (eg triamcinolone, hydrocortisone ); for cosmetics and dermatology |
| 02/24/2005 | US20050043272 nanometer size; polysaccharide backbone linked with hydrophobic hydrocarbon group; small molecules are selected from antitumor agents, nucleic acids, peptides; renders a hydrophobic drug deliverable in a physiological fluid |
| 02/24/2005 | US20050043271 Heparin-containing ophthalmic agent |
| 02/24/2005 | US20050043247 Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative |
| 02/24/2005 | US20050043228 Glp-1 formulations with protracted time action |
| 02/24/2005 | US20050043224 Administering to patient a pharmaceutical preparation comprising at least one chemoprotective inducing agent and a vehicle for delivering chemoprotective inducing agent to cells lining hair follicles, in an amount and for a time effective to reduce or prevent hair loss |
| 02/24/2005 | US20050042452 Microencapsulated particles and process for manufacturing same |
| 02/24/2005 | US20050042313 Method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 02/24/2005 | US20050042304 Novel substituted benzimidazole dosage forms and method of using same |
| 02/24/2005 | US20050042303 Therapeutic protocols |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042298 Immunonanoparticles |
| 02/24/2005 | US20050042297 Granules obtained by drying an emulsion comprising a polymer and a monosaccharide or a monosaccharide derivative |
| 02/24/2005 | US20050042295 Anti-angiogenic compositions and methods of use |
| 02/24/2005 | US20050042294 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 02/24/2005 | US20050042293 Mixture of hydrophobic drug and water soluble polymer; biodegradable insert |
| 02/24/2005 | US20050042292 Intravaginal matrix drug delivery devices |
| 02/24/2005 | US20050042291 Diffusion layer modulated solids |
| 02/24/2005 | US20050042290 Core containing venlafaxine with polymers; overcoated with addition polymer |
| 02/24/2005 | US20050042289 Tablets and methods for modified release of hydrophylic and other active agents |
| 02/24/2005 | US20050042288 Mixture of polymerizable matrix and inorganic filler; orthopedics, surgery |
| 02/24/2005 | US20050042286 Loratadine; wet granulation; dissolving in mouth; blending of antihistamine with binder and filler |
| 02/24/2005 | US20050042285 Storage stability; mixture containing metal compound, polymer |
| 02/24/2005 | US20050042284 Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
| 02/24/2005 | US20050042283 Histamine and CCK2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer |
| 02/24/2005 | US20050042282 Asthma; respiratory system disorders; gastrointestinal disorders; irritable bowel disorders; antiulcer agents |
| 02/24/2005 | US20050042281 Mixture with buffer and carrier; adjust pH of saliva |
| 02/24/2005 | US20050042280 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 02/24/2005 | US20050042279 Pharmaceutical formulation comprising more than 15% tamoxifen |
| 02/24/2005 | US20050042278 Filling capsules with oil mixture |
| 02/24/2005 | US20050042277 Pharmaceutical compositions having a swellable coating |
| 02/24/2005 | US20050042276 Core containing dosage of active materials enclosed in covering containing hydroxypropylmethyl cellulose |
| 02/24/2005 | US20050042275 Epothilone compositions |
| 02/24/2005 | US20050042274 Compounds and compositions for delivering active agents |
| 02/24/2005 | US20050042271 Analgesics; antiinflammatory agents; sustained release |
| 02/24/2005 | US20050042270 Transdermal method and apparatus |
| 02/24/2005 | US20050042269 Multilayer patch having laminated backing and pressure sensitive adhesive; polyester kint fabric impregnated with drug |
| 02/24/2005 | US20050042265 Composition for cutaneous repair and cicatrization comprising exclusively a true physical hydrogel of chitosan |
| 02/24/2005 | US20050042264 For temperary lifting, supporting, smoothing skins; applying adhesive to thin, flexible, translucence sheet |
| 02/24/2005 | US20050042249 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/24/2005 | US20050042248 Mixture of polyol and insulation agent; gelation; dysmenorrhea |
| 02/24/2005 | US20050042241 Topical analgesic and/or antiinflammatory cream; bursitis, tendonitis; dimethyl sulfoxide and a mixture of pluronic gel and lecithin; allows the longer acting pain relievers ketoprofen and diphenhydramine to reach underlying inflamed tissues |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | US20050042198 Ophthalmic and contact lens wetting solutions |
| 02/24/2005 | US20050042194 Semi-solid delivery vehicle and pharmaceutical compositions |
| 02/24/2005 | US20050042182 Topical compositions of urea |
| 02/24/2005 | US20050042180 Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder |
| 02/24/2005 | US20050042179 Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine |